![how to fose how to fose](https://appassets.mvtdev.com/map/41/s/5927/147859371.jpg)
Patients with known or suspected bacteremia.
![how to fose how to fose](https://i.ytimg.com/vi/d6pcA7OsELk/maxresdefault.jpg)
Do not use in patients with pneumonia who may be inappropriate for oral therapy because of moderate to severe illness or risk factors such as any of the following:.Use only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria in order to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin Limitations of use >45.5 kg: 500 mg PO once, then 250 mg once daily for 4 days Pertussis (Off-label)ĥ00 mg PO once, then 250 mg once daily for 4 days Endocarditis (Off-label)Ĭurrent American Heart Association (AHA) guidelines recommend only for high-risk patients Dosing Considerations Novel Coronavirus Resource Center (link ).Coronavirus Disease 2019 (COVID-19) (link ).Note: Limited data available no drug is FDA approved to treat COVID-19Īzithromycin may be considered for use as part of an investigational protocol for patients with COVID-19įor more information, see the CDC website (link ) Additional Medscape COVID-19 references are available If anaerobic microorganisms are suspected of contributing to the infection, administer an antimicrobial agent with anaerobic activity in combination with azithromycin Coronavirus Disease 2019 (COVID-19) (Off-label) Indicated for treatment of pelvic inflammatory disease due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Mycoplasma hominis in patients who require initial IV therapy Indicated for treatment of urethritis and cervicitis due to Chlamydia trachomatis or Neisseria gonorrhoeaeġ000 mg PO x 1 dose Pelvic Inflammatory Disease Indicated for treatment of genital ulcer disease in men due to Haemophilus ducreyi (chancroid)Įfficacy in treatment of chancroid in women has not been establishedġ000 mg PO x 1 dose Nongonococcal or Gonococcal Urethritis and Cervicitis Indicated for treatment of acute bacterial sinusitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeĥ00 mg PO qDay x 3 days Genital Ulcer Disease (Chancroid) Indicated for treatment of acute bacterial exacerbations of chronic bronchitis due to Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniaeĪlternatively, 500 mg PO x 1 dose on Day 1, followed by 250 mg PO qDay on Days 2-5 Acute bacterial sinusitis
#How to fose skin
Indicated for treatment of uncomplicated skin and skin structure infections due to Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiaeĥ00 mg PO x 1 dose on Day 1, followed by 250 mg PO qDay on Days 2-5 Acute bacterial exacerbations of chronic obstructive pulmonary disease Indicated for treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes as an alternative therapy in individuals who cannot use first-line therapyĥ00 mg PO x 1 dose on Day 1, followed by 250 mg PO qDay on Days 2-5 Uncomplicated skin/skin structure
![how to fose how to fose](https://res.cloudinary.com/mtree/image/upload/f_auto,q_auto/Ariel_IN/en-in/-/media/Ariel_IN/Images/Article/2020/How_to_use_and_dose_620x314.png)
Indicated for treatment of community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in patients appropriate for oral therapyĥ00 mg PO x 1 dose on Day 1, followed by 250 mg PO qDay on Days 2-5 Pharyngitis or Tonsillitis Dosage Forms & Strengths injection, lyophilized powder for reconstitution